Table 2. [Dry eye study] Patient demographics and univariate comparisons of clinical parameters.
| Control | Glaucoma | P-value A | |
|---|---|---|---|
| No. subjects | 1431 | 89 | |
| Age (years) | 66.9 ± 9.7 | 67.9 ± 9.2 | n.s. |
| No. males/females | 534/897 | 45/44 | 0.013* |
| Dry eye-related symptoms | |||
| Dryness +/- | 345/1086 | 19/70 | n.s. |
| Eye fatigue +/- | 456/975 | 25/64 | n.s. |
| Photophobia +/- | 247/1176 | 11/78 | n.s. |
| Pain +/- | 93/1333 | 5/84 | n.s. |
| Blurring +/- | 273/1151 | 18/71 | n.s. |
| Dry eye-related signs | |||
| Schirmer test (≤ 5 mm/> 5mm) | 46/134 | 2/8 | n.s. |
| Tear break-up time (≤ 5s/> 5s) | 700/726 | 49/39 | n.s. |
| Corneal staining score | 0.32 ± 0.61 | 0.36 ± 0.64 | n.s. |
| Topical medications other than prostaglandin (% of cases) | |||
| None | 62.5 | 53.8 | 0.866 |
| Sodium hyarulonate | 12.4 | 22.0 | 0.127 |
| Mucin secretagogue | 12.2 | 13.2 | |
| Steroid + Hyarulonate | 3.1 | 0.0 | |
| OthersB | 9.8 | 11.0 | 0.702 |
Unless indicated otherwise, data are given as the mean ± SD.
AP-values were obtained by Chi-squared test and the Mann–Whitney U test, as appropriate; asterisks indicate significant differences.
Bother medications included Kary® Uni and Sancoba®.